EAR2OS: Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques

Sponsor
Prof. Vedat Topsakal (Other)
Overall Status
Completed
CT.gov ID
NCT03746613
Collaborator
(none)
3
1
1
8.2
0.4

Study Details

Study Description

Brief Summary

To assess the feasibility of achieving a minimally invasive access to the inner ear through the navigation-based HEARO procedure and subsequently insert the electrode array of the cochlear implant through the access.

Condition or Disease Intervention/Treatment Phase
  • Device: HEARO
N/A

Detailed Description

  • Demonstrate the feasibility and efficacy of performing a middle and inner ear access for cochlear implantation procedures in adults.

  • Validate the procedure workflow including imaging, planning, safety assessment, image to patient registration, robotic drilling, electrode insertion and device implantation.

  • Validate the system and procedure safety mechanisms.

  • Collect required data for validation of safety algorithms and procedure workflow optimisation.

  • Validate the HEARO system.

Study Design

Study Type:
Interventional
Actual Enrollment :
3 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
Actual Study Start Date :
Sep 24, 2018
Actual Primary Completion Date :
Apr 27, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Minimally invasive robotic cochlear implantation with HEARO

Device: HEARO
Robotic system for otological procedures
Other Names:
  • HEARO procedure
  • Outcome Measures

    Primary Outcome Measures

    1. The relative ratio of successfully completed procedures where a direct access tunnel was drilled to the cochlea with the HEARO® system and the electrode was conventionally inserted through the tunnel. [Image data aquired during the procedure]

    Secondary Outcome Measures

    1. Number of completed middle ear access [The procedure (day 0)]

    2. Number of completed inner ear access [The procedure (day 0)]

    3. Accuracy of the drilled trajectory [Image data aquired during the procedure]

    4. Sensitivity and specificity of facial nerve monitoring [The procedure (day 0)]

    5. Measurement of the insertion angle [Image data aquired during the procedure]

      Measurement of the insertion depth of the electrode into the Cochlea

    6. Number of tip fold-overs [The procedure (day 0)]

    7. Number of Scala deviations [The procedure (day 0)]

    8. Number of complication events on (temporary) facial nerve palsy, pre and post bleeding and infection [day 0-30]

    9. Time of procedure [The procedure (day 0)]

    10. Volume of tissue removed [Image data aquired during the procedure]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients suffering from profound sensorineural deafness requiring a Cochlear implant
    Exclusion Criteria:
    • Age under 18 years

    • Pregnant women

    • Anatomical anomalies of temporal bone

    • Chronic otitis media with or without cholesteatoma

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Antwerp University Hospital Antwerp Belgium 2650

    Sponsors and Collaborators

    • Prof. Vedat Topsakal

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Prof. Vedat Topsakal, Principal Investigator, University Hospital, Antwerp
    ClinicalTrials.gov Identifier:
    NCT03746613
    Other Study ID Numbers:
    • B300201837507
    First Posted:
    Nov 19, 2018
    Last Update Posted:
    Jul 24, 2019
    Last Verified:
    Jul 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Prof. Vedat Topsakal, Principal Investigator, University Hospital, Antwerp
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 24, 2019